Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2299-5684
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure ; volume:73 ; number:5 ; day:11 ; month:6 ; year:2021 ; pages:1427-1438 ; date:10.2021
Pharmacological reports ; 73, Heft 5 (11.6.2021), 1427-1438, 10.2021
- Creator
-
Szeląg-Pieniek, Sylwia
Oswald, Stefan
Post, Mariola
Łapczuk-Romańska, Joanna
Droździk, Marek
Kurzawski, Mateusz
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s43440-021-00290-8
- URN
-
urn:nbn:de:101:1-2021121517495819026703
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Szeląg-Pieniek, Sylwia
- Oswald, Stefan
- Post, Mariola
- Łapczuk-Romańska, Joanna
- Droździk, Marek
- Kurzawski, Mateusz
- SpringerLink (Online service)
Other Objects (12)
p53 attenuates acetaminophen-induced hepatotoxicity by regulating drug-metabolizing enzymes and transporter expression
Phenotypic Models of Drug-Drug-Gene Interactions Mediated by Cytochrome Drug-Metabolizing Enzymes
Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models
Implications of genetic variation of common Drug Metabolizing Enzymes and ABC Transporters among the Pakistani Population
Molecular determinants underlying substrate promiscuity and polymorphism in drug-metabolizing CYP enzymes
Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes
Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology
GASP and FASP are Complementary for LC–MS/MS Proteomic Analysis of Drug‐Metabolizing Enzymes and Transporters in Pig Liver
SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer
Drug transporters
A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation
Effects of marine biotoxins on drug-metabolizing cytochrome P450 enzymes and their regulation in mammalian cells
p53 attenuates acetaminophen-induced hepatotoxicity by regulating drug-metabolizing enzymes and transporter expression
Phenotypic Models of Drug-Drug-Gene Interactions Mediated by Cytochrome Drug-Metabolizing Enzymes
Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models
Implications of genetic variation of common Drug Metabolizing Enzymes and ABC Transporters among the Pakistani Population
Molecular determinants underlying substrate promiscuity and polymorphism in drug-metabolizing CYP enzymes
Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes
Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology
GASP and FASP are Complementary for LC–MS/MS Proteomic Analysis of Drug‐Metabolizing Enzymes and Transporters in Pig Liver
SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer
Drug transporters
A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation
Effects of marine biotoxins on drug-metabolizing cytochrome P450 enzymes and their regulation in mammalian cells
p53 attenuates acetaminophen-induced hepatotoxicity by regulating drug-metabolizing enzymes and transporter expression
Phenotypic Models of Drug-Drug-Gene Interactions Mediated by Cytochrome Drug-Metabolizing Enzymes
Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models
Implications of genetic variation of common Drug Metabolizing Enzymes and ABC Transporters among the Pakistani Population
Molecular determinants underlying substrate promiscuity and polymorphism in drug-metabolizing CYP enzymes
Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes
Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology
GASP and FASP are Complementary for LC–MS/MS Proteomic Analysis of Drug‐Metabolizing Enzymes and Transporters in Pig Liver
SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer
Drug transporters
A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation